1,2-Dichloroethane → (E)-N-(3-ethyl-benzofuran-2-ylmethyl)-N-methyl-3-(2-oxo-2,3,4,5-tetrahydro-1H-pyrido[2,3-e][1,4]diazepin-7-yl)acrylamide

HRID 2097061Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2097061
[CH2:1]([C:3]1[C:7]2[CH:8]=[CH:9][CH:10]=[CH:11][C:6]=2[O:5][C:4]=1[CH2:12][NH:13][CH3:14])[CH3:2].C(N(C(C)C)C(C)C)C.Cl.[O:25]=[C:26]1[NH:32][C:31]2[N:33]=[CH:34][C:35]([CH:37]=[CH:38][C:39]([OH:41])=O)=[CH:36][C:30]=2[CH2:29][NH:28][CH2:27]1.C1C=CC2N(O)N=NC=2C=1.C(Cl)CCl>CN(C=O)C.O>[CH2:1]([C:3]1[C:7]2[CH:8]=[CH:9][CH:10]=[CH:11][C:6]=2[O:5][C:4]=1[CH2:12][N:13]([CH3:14])[C:39](=[O:41])/[CH:38]=[CH:37]/[C:35]1[CH:34]=[N:33][C:31]2[NH:32][C:26](=[O:25])[CH2:27][NH:28][CH2:29][C:30]=2[CH:36]=1)[CH3:2]

Komponenten

8

Versuchsvorschrift

A solution of (3-ethyl-benzofuran-2-ylmethyl)methylamine (185 mg, 0.979 mmol) and (i-Pr)2EtN (0.427 mL, 2.44 mmol) in DMF (25 mL) was treated successively with 3-(2-oxo-2,3,4,5-tetrahydro-1H-pyrido[2,3-e][1,4]diazepin-7-yl)acrylic acid hydrochloride (250 mg, 0.816 mmol), HOBt (115 mg, 0.856 mmol), and EDC (316 mg, 2.44 mmol). After stirring overnight at room temperature, the mixture was diluted with water and then extracted with EtOAc (3×). The combined organics were washed with brine and dried, filtered and concentrated in vacuo. Purification by column chromatography (silica gel, CH2Cl2/CH3OH, 40:2 to 35:2) gave the title compound (125 mg, 37%) as a yellow solid: ESI MS m/z 405 (M+H)+.

Aufarbeitung

  1. extractionextracted with EtOAc (3×)
  2. washThe combined organics were washed with brine
  3. customdried
  4. filtrationfiltered
  5. concentrationconcentrated in vacuo
  6. customPurification by column chromatography (silica gel, CH2Cl2/CH3OH, 40:2 to 35:2)

Quellen und Nachweise

ORD-Eintrag
ord-211320ae8ff247a1b8fbae586d5a31f0
Quelldatensatz
uspto-grants-2013_05
Patentnummer
US08450307B2

Notizen zur Reaktion

Wird geladen…